
# cfDNA and other blood tests

## I. cfDNA

### **Multianalyte & Multiomics**

  * **2024 Cell Reports Medicine** - Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis

  * ✅ **cfDNA+cfDNAmet+cfRNA-S+cfRNA-L** - [**2023&#x20;**_**Cell Reports Medicine**_ ](https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791\(23\)00475-5)- Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood

  * ✅ **cfDNA+cfDNAmet** - [**2023 Cancer Discovery**](https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-23-0456/729598/Early-Cancer-Detection-in-Li-Fraumeni-Syndrome) - Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA&#x20;

  * **cf-WGS+cf-WGBS - 2022&#x20;**_**Cancer Cell**_ - Evaluation of cell-free DNA approaches for multi- cancer early detection

  * **CancerSEEK+PET-CT:&#x20;**_**2020 Science -**_ Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

  * ✅ **\~60 cfDNA + 8 proteins (CancerSEEK):&#x20;**_**2018 Science**_ - Detection and localization of surgically resectable cancers with a multi-analyte blood test


### **cfDNA/mbDNA** 

* **2024 Science Translational Medicine** - Machine learning to detect the SINEs of cancer
* **2023 GB** - The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection
* **2023 Nature Genetics** - Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer
* **2023 STM** - Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
* ✅ [**end-motif **] **2023 PNAS** - Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs
* **2022 Cancer Discovery** - Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes
* **cfDNA SNV+met**: [_**2022 Science Trans. Med.**_ ](https://www.science.org/doi/10.1126/scitranslmed.abp8704)- Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
* **Captured ctDNA SNV+CNV:&#x20;**_**2020 Nature**_ - Integrating genomic features for noninvasive early lung cancer detection
* **Microbiome:&#x20;**_**2020 Nature**_ - Microbiome analyses of blood and tissues suggest cancer diagnostic approach&#x20;
* **Fragmentome (DELFI):** [_**2022 Cancer Discovery**_](https://www.science.org/doi/10.1126/scitranslmed.abp8704) **-** Detecting liver cancer using cell-free DNA fragmentomes
* **Fragmentome (DELFI): 2021 Nature Commn.** - Detection and characterization of lung cancer using cell-free DNA fragmentomes
* ✅ **Fragmentome (DELFI):** _**2019 Nature**_ - Genome-wide cell-free DNA fragmentation in patients with cancer


###  **cfDNA Methylation**

  * ✅ \[Grail, cfDNA vs. cfDNAmet] - [**2022 Cancer Cell** ](https://doi.org/10.1016/j.ccell.2022.10.022)- Evaluation of cell-free DNA approaches for multicancer early detection
  * \[Grail, Targeted BS] _**2022 ESMO congress**_ - PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test
  * \[Grail, Targeted BS] [_**2021 Annals of Oncology**_](https://www.science.org/doi/10.1126/scitranslmed.abp8704) **-** Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
  * \[Grail, Targeted BS] _**2020 Annals of Oncology**_**&#x20;-** Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
  * ✨ \[meDIP] _**2018 Nature**_ - Sensitive tumour detection and classification using plasma cell-free DNA methylomes

### **cfDNAmet and histone modification**

  * [**2023 Nature Medicine** ](https://www.nature.com/articles/s41591-023-02605-z)**-** Liquid biopsy epigenomic profiling for cancer subtyping
  * **2021 Nature Biotech.** - ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin




## II. Others

### **cfRNA**

see [cfRNA](cfRNA.md)

### **TCR**

* **2020** - _**Science Transl. Med.**_ - De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection

### **Proteome**

* ✅ \[Plasma proteome] [**2023&#x20;**_**Nature**_ ](https://www.nature.com/articles/s41586-023-06802-1)**-** Organ aging signatures in the plasma proteome track health and disease
* \[Plasma proteome] _**2022 Nature Medicine**_ - Noninvasive proteomic biomarkers for alcohol-related liver disease
* ✅  \[MS-EVP] **Exosomic proteins**: _**2020 Cell**_ - Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
* \[APPA] _**2020 Sci Adv** -_ Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response

### **Metabolome**

* **2024 Nature Commn.** - Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer

